Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,187 | 4,466 | 5,048 | 5,664 | 5,062 |
| Operating Income | -4,187 | -4,466 | -5,048 | -5,664 | -5,062 |
| Interest Expense | 38 | 42 | 41 | 52 | 72 |
| Other Income | 121 | 447 | -82 | -41 | 75 |
| Pre-tax Income | -4,104 | -4,061 | -5,171 | -5,757 | -5,059 |
| Income Tax | 4 | -2 | 10 | 4 | 3 |
| Net Income Continuous | -4,108 | -4,059 | -5,181 | -5,761 | -5,062 |
| Minority Interests | N/A | -3 | -32 | -46 | -76 |
| Net Income | $-4,108 | $-4,056 | $-5,149 | $-5,715 | $-4,986 |
| EPS Basic Total Ops | -0.43 | 0.46 | -2.21 | -1.99 | -2.21 |
| EPS Basic Continuous Ops | -0.40 | 0.64 | -1.06 | -2.00 | -2.24 |
| EPS Diluted Total Ops | -0.43 | 0.46 | -2.21 | -1.99 | -2.21 |
| EPS Diluted Continuous Ops | -0.40 | 0.64 | -1.06 | -2.00 | -2.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.57 | -2.21 | -1.99 | -2.16 |
| EBITDA(a) | $-3,761 | $-4,043 | $-4,621 | $-5,257 | $-4,668 |